These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32437509)

  • 1. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.
    Xu X; Hou B; Fulzele A; Masubuchi T; Zhao Y; Wu Z; Hu Y; Jiang Y; Ma Y; Wang H; Bennett EJ; Fu G; Hui E
    J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32437509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
    Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E
    Elife; 2021 Nov; 10():. PubMed ID: 34734802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy.
    Celis-Gutierrez J; Blattmann P; Zhai Y; Jarmuzynski N; Ruminski K; Grégoire C; Ounoughene Y; Fiore F; Aebersold R; Roncagalli R; Gstaiger M; Malissen B
    Cell Rep; 2019 Jun; 27(11):3315-3330.e7. PubMed ID: 31189114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A THEMIS:SHP1 complex promotes T-cell survival.
    Paster W; Bruger AM; Katsch K; Grégoire C; Roncagalli R; Fu G; Gascoigne NR; Nika K; Cohnen A; Feller SM; Simister PC; Molder KC; Cordoba SP; Dushek O; Malissen B; Acuto O
    EMBO J; 2015 Feb; 34(3):393-409. PubMed ID: 25535246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Themis-associated phosphatase activity controls signaling in T cell development.
    Mehta M; Brzostek J; Chen EW; Tung DWH; Chen S; Sankaran S; Yap J; Rybakin V; Gascoigne NRJ
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11331-E11340. PubMed ID: 30413615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
    Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL
    J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
    Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor.
    Peled M; Tocheva AS; Sandigursky S; Nayak S; Philips EA; Nichols KE; Strazza M; Azoulay-Alfaguter I; Askenazi M; Neel BG; Pelzek AJ; Ueberheide B; Mor A
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E468-E477. PubMed ID: 29282323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.
    Hwang HJ; Lee JJ; Kang SH; Suh JK; Choi ES; Jang S; Hwang SH; Koh KN; Im HJ; Kim N
    Immun Inflamm Dis; 2021 Mar; 9(1):274-287. PubMed ID: 33332777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.
    Kuo E; Park DK; Tzvetanova ID; Leiton CV; Cho BS; Colognato H
    J Neurochem; 2010 Apr; 113(1):200-12. PubMed ID: 20132481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
    Taylor J; Bulek A; Gannon I; Robson M; Kokalaki E; Grothier T; McKenzie C; El-Kholy M; Stavrou M; Traynor-White C; Lim WC; Panagiotou P; Srivastava S; Baldan V; Sillibourne J; Ferrari M; Pule M; Thomas S
    Front Immunol; 2023; 14():1119350. PubMed ID: 37334382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.
    Kinosada H; Yasunaga JI; Shimura K; Miyazato P; Onishi C; Iyoda T; Inaba K; Matsuoka M
    PLoS Pathog; 2017 Jan; 13(1):e1006120. PubMed ID: 28046066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
    Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
    Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
    Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1.
    Brockdorff J; Williams S; Couture C; Mustelin T
    Eur J Immunol; 1999 Aug; 29(8):2539-50. PubMed ID: 10458769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function.
    Strazza M; Adam K; Lerrer S; Straube J; Sandigursky S; Ueberheide B; Mor A
    Inflammation; 2021 Aug; 44(4):1529-1539. PubMed ID: 33624224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
    Yokosuka T; Takamatsu M; Kobayashi-Imanishi W; Hashimoto-Tane A; Azuma M; Saito T
    J Exp Med; 2012 Jun; 209(6):1201-17. PubMed ID: 22641383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors.
    Sun WZ; Lin HW; Chen WY; Chien CL; Lai YL; Chen J; Chen YL; Cheng WF
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.
    Cai G; Nie X; Li L; Hu L; Wu B; Lin J; Jiang C; Wang H; Wang X; Shen Q
    J Gastroenterol; 2013 Dec; 48(12):1362-72. PubMed ID: 23532637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.